VIP (Vasoactive Intestinal Peptide) Price Comparison — Compare 11 Vendors

View full research →
CIRS (Chronic Inflammatory Response Syndrome)Safety Rating 6/10

Price Comparison

Compare vendors · per 10mg

11 vendors competing

VendorPrice$ / mgUpdated
Ascension Peptides8.5/10$47.00$94.00−50% · code peptidepri$4.70Apr 16, 2026Buy →
Puratek Peptides9.5/10$48.56$53.95−10% · code PEPTIDEPRICES$4.86May 19, 2026Buy →
Midwest Peptide8.5/10$58.49$64.99−10% · code PEPTIDEPRICES$5.85Jun 18, 2026Buy →
Glacier Aminos9.5/10$59.39$65.99−10% · code peptidep$5.94Jun 23, 2026Buy →
Peptira6/10$89.00$8.90May 14, 2026Buy →
CertaPeptides7.5/10Out of stock$92.27$102.52−10% · code PEPTIDEPRICES$9.23Jun 27, 2026Buy →

Research details

VIP — research data

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range50 mcg intranasal 4x/day (Shoemaker protocol for CIRS). SC dosing also used. Cycle individualized.
AdministrationIntranasal
Safety6/10 · Not FDA-approved
NCAA D1Not listed

Overview

About VIP

Mechanism of action

Neuropeptide that binds VPAC1/VPAC2 receptors; vasodilator; bronchodilator; potent anti-inflammatory; modulates immune function; regulates circadian rhythms and neurotransmission.

Safety profile

Flushing, headache, nausea, hypotension (especially IV). Intranasal generally well-tolerated. · Endogenous neuropeptide; clinical use for pulmonary conditions; vasodilation, diarrhea; tolerable

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on VIP

Failed to fetch